On the 14th of May 2021 we have successfully initiated the additional trial that was planned at the University of Crete in Greece in which Principal Investigator is Prof. Efstathios Detorakis. The intention being for launching this extra clinical trial is to elaborate more on the clinical findings in a small number of patients.